The U.S. Food and Drug Administration on Monday issued emergency authorization for a Zika diagnostics test from Swiss drugmaker Roche, skirting normal approval channels as the regulator moves to fight the disease’s spread.
{iframe}http://www.reuters.com/article/us-roche-zika-idUSKCN1140BL{/iframe}